StockData

Centene vs Molina Healthcare

CNC and MOH side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CNC and MOH compare

Centene is the larger company, worth 3.0 times as much as Molina Healthcare ($37.0B against $12.2B).

Centene grew revenue faster over the last twelve months (9.7% versus −0.95% for Molina Healthcare).

Centene keeps more of each dollar of sales as profit, with a net margin of 0.72% compared with −0.11% at Molina Healthcare.

Centene scores higher on the StockData Score (7 against 5 for Molina Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCNCMOH
Size and price
Market cap$37.0B$12.2B
Share price$74.77$233.09
Change, 1 year107%68.3%
Change, 5 years1.2%−20.3%
Beta (5Y)1.13−0.06
Employees61K19K
StockData Score
Total score7 (better)5
Valuation score2 (better)1
Growth score12 (better)
Performance score2 (better)0
Health score22
Dividend score00
Valuation
P/E25.6×–
P/S0.2× (better)0.3×
P/B1.7× (better)2.9×
EV/EBITDA13.0× (better)22.1×
P/FCF9.4× (better)51.1×
FCF yield10.7% (better)2.0%
Fair value$68.78–
Margin of safety−8.7%–
Growth
Revenue growth (TTM)9.7% (better)−0.95%
Revenue growth, 5Y average11.9%18.5% (better)
Net income growth (TTM)–−105%
EPS growth (TTM)–−106%
EPS growth, 5Y average–−4.5%
Profitability
Gross margin7.9%12.6% (better)
Operating margin0.49% (better)0.39%
Net margin0.72% (better)−0.11%
FCF margin1.9% (better)0.54%
Return on equity6.8% (better)−1.2%
Return on invested capital4.6%–
Financial health
Debt / equity0.70 (better)0.91
Net debt / EBITDA−3.60−14.44
Interest coverage1.6× (better)0.8×
Current ratio1.161.69 (better)
Altman Z-score3.304.22 (better)
Piotroski F-score44
Dividends and buybacks
Buyback yield0.07% (better)0.00%
Shareholder yield0.07% (better)0.00%
Ownership
Held by institutions98.6%108%
Held by insiders0.79%2.1%
Insider net buying, 12 months−$14.6M−$5.5M (better)
Superinvestors holding3 (better)2
Short interest, % of float2.1%5.7%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.